Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets, Volume 16 - Number 4



CYLD-Mediated Signaling and Diseases

, 16(4): 284 - 294

Bryan J. Mathis, Yimu Lai, Chen Qu, Joseph S. Janicki and Taixing Cui


DOI: 10.2174/1389450115666141024152421



The Role of Adipocytokines in Atherogenesis and Atheroprogression

, 16(4): 295 - 320

Federico Carbone, Francois Mach and Fabrizio Montecucco


DOI: 10.2174/1389450115666141109213439



Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability

, 16(4): 321 - 333

Federico Carbone, Francois Mach and Fabrizio Montecucco


DOI: 10.2174/1389450115666141110093013






Indoxyl Sulfate: A Candidate Target for the Prevention and Treatment of Cardiovascular Disease in Chronic Kidney Disease

, 16(4): 366 - 372

Chiara Barisione, Giorgio Ghigliotti, Marco Canepa, Manrico Balbi, Claudio Brunelli and Pietro Ameri


DOI: 10.2174/1389450116666141230114500








Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.91

Related Journals

Related eBooks

eBooks Catalog